Surmodics (SRDX) Competitors $29.30 -0.41 (-1.36%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRDX vs. ATEC, ATRC, IART, ANGO, OFIX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), AngioDynamics (ANGO), Orthofix Medical (OFIX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Surmodics vs. Its Competitors Alphatec AtriCure Integra LifeSciences AngioDynamics Orthofix Medical Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Alphatec (NASDAQ:ATEC) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Which has better valuation & earnings, ATEC or SRDX? Surmodics has lower revenue, but higher earnings than Alphatec. Surmodics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlphatec$611.56M2.67-$162.12M-$1.15-9.73Surmodics$126.08M3.32-$11.54M-$1.39-21.08 Do analysts rate ATEC or SRDX? Alphatec presently has a consensus price target of $17.89, indicating a potential upside of 59.94%. Surmodics has a consensus price target of $43.00, indicating a potential upside of 46.73%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts clearly believe Alphatec is more favorable than Surmodics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Surmodics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is ATEC or SRDX more profitable? Surmodics has a net margin of -16.34% compared to Alphatec's net margin of -25.77%. Surmodics' return on equity of -7.10% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Alphatec-25.77% -1,657.19% -21.53% Surmodics -16.34%-7.10%-4.77% Does the media refer more to ATEC or SRDX? In the previous week, Alphatec had 5 more articles in the media than Surmodics. MarketBeat recorded 6 mentions for Alphatec and 1 mentions for Surmodics. Surmodics' average media sentiment score of 1.89 beat Alphatec's score of 0.92 indicating that Surmodics is being referred to more favorably in the news media. Company Overall Sentiment Alphatec Positive Surmodics Very Positive Do insiders and institutionals believe in ATEC or SRDX? 66.4% of Alphatec shares are owned by institutional investors. Comparatively, 96.6% of Surmodics shares are owned by institutional investors. 22.8% of Alphatec shares are owned by company insiders. Comparatively, 8.9% of Surmodics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, ATEC or SRDX? Alphatec has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. SummaryAlphatec and Surmodics tied by winning 8 of the 16 factors compared between the two stocks. Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$419.06M$10.31B$5.52B$8.87BDividend YieldN/A2.10%5.36%4.13%P/E Ratio-21.0817.2526.5019.82Price / Sales3.3226.91410.19110.66Price / Cash93.1223.5625.8827.49Price / Book3.523.697.945.39Net Income-$11.54M$233.36M$3.15B$248.34M7 Day Performance1.02%1.77%1.08%1.25%1 Month Performance0.91%3.18%5.34%5.41%1 Year Performance-30.06%-12.03%32.80%18.07% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics4.4539 of 5 stars$29.31-1.4%$43.00+46.7%-29.3%$419.06M$126.08M-21.08450Positive NewsATECAlphatec4.2139 of 5 stars$10.86-0.7%$17.89+64.7%+6.2%$1.60B$611.56M-9.44700ATRCAtriCure3.5236 of 5 stars$31.90+1.6%$50.67+58.8%+43.9%$1.55B$465.31M-39.381,300Positive NewsIARTIntegra LifeSciences4.0609 of 5 stars$11.62+0.2%$18.63+60.3%-57.9%$901.46M$1.61B-30.584,396ANGOAngioDynamics3.9797 of 5 stars$9.99-0.3%$14.00+40.1%+64.0%$406.88M$303.91M-9.89760Positive NewsOFIXOrthofix Medical3.2225 of 5 stars$10.80+4.4%$21.50+99.1%-15.9%$404.93M$799.49M-2.931,616ARAYAccuray3.5655 of 5 stars$1.25+2.5%N/A-24.7%$125.68M$446.55M-25.001,040Positive NewsRMTIRockwell Medical4.1805 of 5 stars$0.87-2.2%$4.00+359.5%-51.8%$30.42M$101.49M-43.53300RSLSReShape Lifesciences0.1178 of 5 stars$2.56+0.4%N/A-99.1%$6.08M$8.01M-0.0150ABTAbbott Laboratories4.8889 of 5 stars$133.26+0.2%$142.61+7.0%+31.0%$231.38B$41.95B17.28114,000Positive NewsISRGIntuitive Surgical4.6975 of 5 stars$515.09+1.1%$588.95+14.3%+22.2%$182.56B$8.35B75.5315,638Positive News Related Companies and Tools Related Companies Alphatec Competitors AtriCure Competitors Integra LifeSciences Competitors AngioDynamics Competitors Orthofix Medical Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRDX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts